Manufactures antibodies and diagnostic reagents for brain diseases.
Jun 2026Revenue $237M/yrExpenses $230M/yr
No trend
Figures by year
Is Janel profitable?
Yes. In the 12 months to Jun 2026, revenue was $237M and expenses $230M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Sep 2025 | $207M | $201M | $6.43M |
| Sep 2024 | $183M | $179M | $3.76M |
| Sep 2023 | $186M | $184M | $2.60M |
| Sep 2022 | $317M | $307M | $9.50M |
| Sep 2021 | $146M | $142M | $3.95M |
| Sep 2020 | $82.4M | $84.2M | −$1.72M |
| Sep 2019 | $84.4M | $82.8M | $1.58M |
| Sep 2018 | $67.5M | $66.6M | $887K |
| Sep 2017 | $58.9M | $56.8M | $2.10M |
| Sep 2016 | $75.3M | $73.2M | $2.16M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.